Alyeska Investment Group »

Catalyst Pharmaceutical Partners shares owned by Alyeska Investment Group

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Alyeska Investment Group from 13F filings

Historical chart of Alyeska Investment Group investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Alyeska Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Alyeska Investment Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.4M 273k 19.70

More positions owned by Alyeska Investment Group

Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Apple (AAPL)
salesforce (CRM)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Bank of America Corporation (BAC)
Take-Two Interactive Software (TTWO)
Microsoft Corporation (MSFT)
Coherent Corp (COHR)
Home Depot (HD)
McDonald's Corporation (MCD)
Twilio Cl A (TWLO)
Arista Networks Com Shs (ANET)

View all positions for Alyeska Investment Group

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Renaissance Technologies
Fundsmith
Morgan Stanley
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
Royce & Associates
Millennium Management
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners